Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors

Clinical trial NCT05115344 · WITHDRAWN

Trial details

NCT number: NCT05115344
Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloproliferative Neoplasm (MPN)Myelofibrosis，MF

Start date: 2021-11-12
Primary completion: 2022-12-29
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.